BRPI0908493A2 - composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares - Google Patents

composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares

Info

Publication number
BRPI0908493A2
BRPI0908493A2 BRPI0908493A BRPI0908493A BRPI0908493A2 BR PI0908493 A2 BRPI0908493 A2 BR PI0908493A2 BR PI0908493 A BRPI0908493 A BR PI0908493A BR PI0908493 A BRPI0908493 A BR PI0908493A BR PI0908493 A2 BRPI0908493 A2 BR PI0908493A2
Authority
BR
Brazil
Prior art keywords
phytoestrogens
compositions
estrogen receptor
selective estrogen
dietary fibers
Prior art date
Application number
BRPI0908493A
Other languages
English (en)
Inventor
Michele Barone
Leo Alfredo Di
Original Assignee
Cm & D Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm & D Pharma Ltd filed Critical Cm & D Pharma Ltd
Publication of BRPI0908493A2 publication Critical patent/BRPI0908493A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
BRPI0908493A 2008-02-22 2009-02-20 composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares BRPI0908493A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000008A ITBA20080008A1 (it) 2008-02-22 2008-02-22 Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
PCT/EP2009/052038 WO2009103788A1 (en) 2008-02-22 2009-02-20 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres

Publications (1)

Publication Number Publication Date
BRPI0908493A2 true BRPI0908493A2 (pt) 2019-09-24

Family

ID=40291378

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908493A BRPI0908493A2 (pt) 2008-02-22 2009-02-20 composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares

Country Status (20)

Country Link
US (2) US20110027230A1 (pt)
EP (1) EP2254573B9 (pt)
JP (1) JP2011512386A (pt)
KR (1) KR20100131985A (pt)
CN (1) CN101951900A (pt)
BR (1) BRPI0908493A2 (pt)
CA (1) CA2714668C (pt)
CO (1) CO6361919A2 (pt)
DK (1) DK2254573T5 (pt)
EA (1) EA020095B1 (pt)
ES (1) ES2387530T3 (pt)
IL (1) IL207670A (pt)
IT (1) ITBA20080008A1 (pt)
MX (1) MX2010009021A (pt)
MY (1) MY150407A (pt)
NZ (1) NZ587116A (pt)
PT (1) PT2254573E (pt)
UA (1) UA101178C2 (pt)
WO (1) WO2009103788A1 (pt)
ZA (1) ZA201006767B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140329770A1 (en) 2011-09-30 2014-11-06 Cm&D Pharma Limited Compositions Comprising Phytoestrogens Receptor Beta Agonists and Dietary Fibers for Chemopreventive Treatment of Sporadic Adenomatous Polyposis
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
US12274276B2 (en) * 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
CN111471117A (zh) 2014-07-09 2020-07-31 卡德纳生物有限公司 低聚糖组合物及其制备方法
CA2975095A1 (en) 2015-01-26 2016-08-04 Cadena Bio, Inc. Oligosaccharide compositions for use as animal feed and methods of producing thereof
WO2016172657A2 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
EP3329787B1 (en) * 2015-10-19 2020-02-05 Famenity Co., Ltd. Functional composition for improvement and prevention of estrogen deficiency in menopausal women
CN106822217B (zh) * 2017-02-20 2020-05-05 天津医科大学总医院 蔓越莓冻干粉在制备防治家族性腺瘤性息肉病药物中的应用
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
US20230148644A1 (en) * 2017-12-08 2023-05-18 Chr. Hansen HMO GmbH Spray-Dried Tetrasaccharides
WO2019110801A1 (en) * 2017-12-08 2019-06-13 Jennewein Biotechnologie Gmbh Spray-dried 3-fucosyllactose
WO2020161522A1 (en) 2019-02-06 2020-08-13 Thd S.P.A. Fiber-based composition
US20240358782A1 (en) * 2020-05-05 2024-10-31 Victor Abou Nehmi Filho Regulatory Composition of the Neuro-Immune-Endocrine and Cortisol Reducing System of the Human Being

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625129D0 (en) * 1996-12-03 1997-01-22 Cerestar Holding Bv Highly fermentable resistant starch
JP3497362B2 (ja) * 1997-11-12 2004-02-16 株式会社朝日商事 発癌抑制薬
WO2000049896A1 (en) * 1999-02-24 2000-08-31 Geza Bruckner Dietary compositions and methods
WO2001021165A1 (en) * 1999-09-21 2001-03-29 Rutgers, The State University Resveratrol analogs for prevention of disease
AU2002366638A1 (en) * 2001-12-06 2003-06-23 Scolr Pharma, Inc. Isoflavone composition for oral delivery
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
CZ20033042A3 (cs) 2003-11-10 2005-06-15 Naturprodukt Cz Spol. S R. O. Potravinový doplněk na bázi silymarinu
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
WO2007140613A1 (en) * 2006-06-06 2007-12-13 Mcgill University Fermented milk product and use thereof

Also Published As

Publication number Publication date
EA201001343A1 (ru) 2011-02-28
IL207670A0 (en) 2010-12-30
EA020095B1 (ru) 2014-08-29
MX2010009021A (es) 2010-11-12
US20110027230A1 (en) 2011-02-03
JP2011512386A (ja) 2011-04-21
NZ587116A (en) 2012-02-24
PT2254573E (pt) 2012-08-08
UA101178C2 (ru) 2013-03-11
EP2254573B9 (en) 2012-09-26
ZA201006767B (en) 2011-06-29
US20140105864A1 (en) 2014-04-17
CO6361919A2 (es) 2012-01-20
CA2714668C (en) 2017-01-10
WO2009103788A9 (en) 2010-02-04
KR20100131985A (ko) 2010-12-16
CA2714668A1 (en) 2009-08-27
IL207670A (en) 2013-12-31
EP2254573A1 (en) 2010-12-01
ES2387530T9 (es) 2013-01-15
DK2254573T5 (da) 2012-09-17
DK2254573T3 (da) 2012-08-20
ES2387530T3 (es) 2012-09-25
EP2254573B1 (en) 2012-05-16
ITBA20080008A1 (it) 2009-08-23
WO2009103788A1 (en) 2009-08-27
AU2009216653A1 (en) 2009-08-27
CN101951900A (zh) 2011-01-19
MY150407A (en) 2014-01-15

Similar Documents

Publication Publication Date Title
BRPI0908493A2 (pt) composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares
BRPI0820447A2 (pt) Agonistas do receptor de glicocorticóides
BRPI0820462A2 (pt) Arranjo de poltronas para aeronave e poltrona
GB0712199D0 (en) Network tester
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
DK2214679T3 (da) Kortikosteroidsammensætninger
BRPI0813892A2 (pt) composições que compreendem antígenos pneumococcal
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
ZA200906495B (en) Klotho beta
IL256822B (en) Oligomer-opioid agonist conjugates, compositions comprising same and uses thereof
EP2173174A4 (en) FARNESOID X RECEPTOR AGONISTS
EP2313111A4 (en) GREAT RECEPTOR AGONIST FORMULATIONS AND THEIR USE
EP2170072A4 (en) Farnesoid X RECEPTOR AGONISTS
PT2144998T (pt) Métodos e composições para vírus vivos atenuados
BRPI0821496A2 (pt) Composições nanopartículas que proporcionam aprimorada coloração para formulações cosméticas
BRPI0818079A2 (pt) composição de lipideo
DK2081951T3 (da) Progesteron-receptorantagonister
BRPI0812818A2 (pt) Turbo-reator para aeronave
ZA201000983B (en) Methods and compositions for diagnosing disease
ZA201001252B (en) Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
BRPI0819281A2 (pt) Composições de fibra inorgânica
EP2320729A4 (en) GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
BRPI0913033A2 (pt) projeto de pad para mram-stt
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina
BRPI0917375A2 (pt) composicoes e metodos para fornecimento de um beneficio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.